Trump Ban on Clinic Abortion Referrals to Be Reversed
WEDNESDAY, April 14, 2021 -- A Trump-era ban on federally funded clinics referring women for abortions will be reversed by the Biden administration, but the process could take months.
Some opponents of the ban -- called a "gag rule" by women's groups and condemned by medical associations -- wanted it immediately suspended, but White House officials believe that going slowly will ultimately increase the likelihood that the reversal will withstand legal challenges, the Associated Press reported.
The Trump ban forced Planned Parenthood out of the federal family planning program called Title X and made it more difficult for women to get birth control. The program provides about $286 million a year in grants for clinics that serve mainly low-income women and provide birth control and basic health care services such as cancer screenings, the AP reported.
The law that created the program in 1970 stipulates that taxpayer money may not be used "where abortion is a method of family planning." In the decades since, there has been ongoing debate between abortion rights supporters and opponents about whether counseling women about abortion or referring them to a different provider for an abortion violates that language, the AP reported.
© 2021 HealthDay. All rights reserved.
Posted: April 2021
Read this next
MONDAY, April 19, 2021 -- Trump-era restrictions on the use of fetal tissue for medical research have been lifted by the Biden administration. The reversal of the restrictions...
TUESDAY, April 13, 2021 -- A requirement that mifepristone abortion pills be dispensed only in person by a medical provider will be put on hold during the COVID-19 pandemic, the...
THURSDAY, Jan. 28, 2021 -- U.S. President Joe Biden on Thursday signed an executive order to reopen enrollment in Affordable Care Act health insurance marketplaces and also signed...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.